Luteinizing hormone (LH) is a hormone synthesized and secreted by gonadotropes in the anterior lobe of the pituitary gland. In concert with the other pituitary gonadotropin follicle stimulating hormone (FSH) it is necessary for proper reproductive function. In the female, an acute rise of LH – the LH surge - triggers ovulation. In the male, where LH had also been called Interstitial Cell Stimulating Hormone (ICSH), it stimulates Leydig cell production of testosterone.
Structure
LH is a
glycoprotein. Each monomeric unit is a
protein molecule with a sugar attached to it; two of these make the full, functional protein. Its structure is similar to the other glycoproteins,
FSH,
TSH, and
hCG. The protein dimer contains 2
polypeptide units, labeled alpha and beta subunits that are connected by two disulfide bridges. The
alpha subunits of LH, FSH, TSH, and hCG are identical, and contain 92
amino acids. The beta subunits vary. LH has a beta subunit of 121 amino acids (LHB) that confers its specific biologic action and is responsible for interaction with the
LH receptor. This beta subunit contains the same amino acids in sequence as the beta sub unit of
hCG and both stimulate the same receptor, however, the hCG beta subunit contains an additional 24 amino acids, and both hormones differ in the composition of their sugar moieties. The different composition of these
oligosaccharides affects bioactivity and speed of degradation. The biologic
half-life of LH is 20 minutes, shorter than that of FSH (3-4 hours) or hCG (24 hours).
Genes
The
gene for the alpha subunit is located on
chromosome 6q12.21. The luteinizing hormone beta-subunit gene is localized in the LHB/CGB gene cluster on
chromosome 19q13.32. In contrast to the alpha gene activity, beta LH subunit gene activity is restricted to the pituitary gonadotropic cells. It is regulated by the
gonadotropin releasing hormone from the
hypothalamus.
Inhibin,
activin, and
sex hormones do not affect genetic activity for the beta subunit production of LH.
Activity
In both males and females, LH is essential for reproduction. In females, at the time of menstruation, FSH initiates follicular growth, specifically affecting granulosa cells. With the rise in estrogens, also LH receptors are expressed on the maturing follicle that produces an increasing amount of
estradiol. Eventually at the time of the maturation of the follicle, the estrogen rise leads via the hypothalamic interface to the “positive feed-back” effect, a release of LH over a 24-48 hour. This
LH surge triggers
ovulation hereby not only releasing the egg, but also initiating the conversion of the residual follicle into a
corpus luteum that, in turn, produces
progesterone to prepare the
endometrium for a possible
implantation. LH is necessary to maintain luteal function for the first two weeks. In case of a
pregnancy luteal function will be further maintained by the action of hCG from the newly established pregnancy.
LH supports
theca cells in the ovary that provide
androgens and hormonal precursors for estradiol production.
In the male, LH acts upon the Leydig cell of the testis and is responsible for testosterone production that exerts intratesticular activity in terms of the spermatogenesis and endocrine activity as the “male hormone”.
The release of LH at the pituitary gland is controlled by pulses of gonadotropin-releasing hormone (GnRH) from the hypothalamus. Those pulses, in turn, are subject to the estrogen feed-back from the gonads.
Normal levels
LH levels are normally low during
childhood and, in women, high after
menopause. During the reproductive years typical levels are seen between 5-20 mIU/ml. Physiologic high LH levels are seen during the LH surge (v.s.), typically they last 48 hours.
Ovulation predictor kit (LH kit)
The detection of the LH surge has become useful for people who want to know when ovulation occurs. LH can be detected by urinary ovulation predictor kits (OPK, also LH-kit) that are performed daily around the time ovulation may be expected. The conversion from a negative to a positive reading would suggest that ovulation is about to occur within 24-48 hours. Couples who plan to conceive would time intercourse accordingly. As sperms can stay viable in the woman for several days, such tests are not recommended for contraceptive practices.
Disease States
Relative elevations
In children with precocious puberty of pituitary or central origin, LH and FSH levels may be in the reproductive range and not at the low levels typically for their age.
During the reproductive years, relatively elevated LH are frequently seen in patients with the polycystic ovary syndrome, however it would be unusual to have LH levels outside of the normal reproductive range.
High LH levels
Persistently high LH levels are indicative of situations where the normal restricting feedback from the gonad is absent, leading to an unrestricted pituitary production of both, LH and FSH. While this is typical in the menopause, it is abnormal in the reproductive years. There it may be a sign of:
- Premature menopause
- Gonadal dysgenesis, Turner syndrome
- Castration
- Swyer syndrome
- Certain forms of CAH
- Testicular failure
Deficient LH activity
Diminished secretion of LH can result in failure of gonadal function (hypogonadism). This condition is typically manifest in males as failure in production of normal numbers of sperm. In females,
amenorrhea is commonly observed.
Conditions with very low FSH secretions are:
- Kallmann syndrome
- Hypothalamic suppression
- Hypopituitarism
- Eating disorder
- Hyperprolactinemia
- Gonadotropin deficiency
- Gonadal suppression therapy
- GnRH antagonist
- GnRH agonist (downregulation)
Availability
LH is available mixed with FSH in the form of
Pergonal, and other forms of urinary
gonadotropins . More purified forms of urinary gonadotropins may reduce the LH portion in relation to FSH. Recombinant LH is available as lutropin alfa (Luveris®)
[Luveris information]. All these medications have to be given parentally. They are commonly in infertility therapy to stimulate follicular development, notably in
IVF therapy.
Often, hCG medication is used as an LH substitute as it activates the same receptor. Medically used hCG is derived from urine of pregnant women, less costly, and has a longer half-life than LH.
References
- , Luteinizing hormone, beta polypeptide; LHB
- , LH-receptor; LHCGR
External links
Recombinant proteins | Glycoproteins | Peptide hormones | Sex hormones | Gonadotropic hormones
Luteinisierendes Hormon | Hormona luteinizante | Hormone lutéinisante | LH | Liuteinizuojantis hormonas | Лутеинизирачки хормон | Luteïniserend hormoon | 黄体形成ホルモン | Hormon luteinizujący | LH | Лютеинизирующий гормон | Luteinizačný hormón